|
C16ORF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44249065417534E-15 |
| Normal-vs-Stage2 |
5.170200E-04 |
| Normal-vs-Stage3 |
1.44150000003229E-06 |
| Normal-vs-Stage4 |
8.34640000000331E-05 |
| Stage1-vs-Stage2 |
6.948000E-01 |
| Stage1-vs-Stage3 |
4.404200E-01 |
| Stage1-vs-Stage4 |
1.411990E-01 |
| Stage2-vs-Stage3 |
3.082000E-01 |
| Stage2-vs-Stage4 |
5.419500E-02 |
| Stage3-vs-Stage4 |
3.050600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.13919999999534E-05 |
| Normal-vs-Asian |
1.535980E-01 |
| Caucasian-vs-AfricanAmerican |
8.632500E-02 |
| Caucasian-vs-Asian |
5.139800E-01 |
| AfricanAmerican-vs-Asian |
9.835600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
9.72860000003628E-07 |
| Male-vs-Female |
2.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.24270000004356E-06 |
| Normal-vs-Extreme_Weight |
1.77635683940025E-15 |
| Normal-vs-Obese |
7.48719997112346E-09 |
| Normal-vs-Extreme_Obese |
3.449700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.343600E-01 |
| Normal_Weight-vs-Obese |
8.392000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.159600E-01 |
| Extreme_Weight-vs-Obese |
4.173800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.540400E-01 |
| Obese-vs-Extreme_Obese |
6.631400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.178000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
7.023400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.984800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.818000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.178000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.564640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.255200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.860000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.97979999949638E-07 |
| Normal-VS-KIRP CIMP |
1.430480E-02 |
| Normal-VS-Unclassified PRCC |
3.8388999999972E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.844200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.164000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.460400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.191800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.376400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.674600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.09620037678371E-10 |
| Normal-vs-N1 |
7.97940000000219E-05 |
| Normal-vs-N2 |
7.765600E-02 |
| N0-vs-N1 |
8.261000E-01 |
| N0-vs-N2 |
1.375830E-01 |
| N1-vs-N2 |
1.477580E-01 |
|
|
